Martinez-Horta, S, Bejr-Kasem, H, Horta-Barba, A, Pascual-Sedano, B, Santos-Garcia, D, De Deus-Fonticoba, T, Jesus, S, Aguilar, M, Planellas, L, Garcia-Caldentey, J, Caballol, N, Vives-Pastor, B, Hernandez-Vara, J, Cabo-Lopez, I, Lopez-Manzanares, L, Gonzalez-Aramburu, I, Avila-Rivera, MA, Catalan, MJ, Lopez-Diaz, LM, Puente, V, Garcia-Moreno, JM, Borrue, C, Solano-Vila, B, Alvarez-Sauco, M, Vela, L, Escalante, S, Cubo, E, Carrillo-Padilla, F, Martinez-Castrillo, JC, Sanchez-Alonso, P, Alonso-Losada, MG, Lopez-Ariztegui, N, Gaston, I, Blazquez-Estrada, M, Seijo-Martinez, M, Ruiz-Martinez, J, Valero-Merino, C, Kurtis, M, De Fabregues-Boixar, O, Gonzalez-Ardura, J, Prieto-Jurczynska, C, Martinez-Martin, P, Mir, P, Kulisevsky, J. Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson's disease. BMC Neurology. 2021; 21(1)DOI:10.1186/s12883-021-02485-1. PMID:34879838. IF:2.903(Q3/7D).

Garcia, DS, Rios, LN, Fonticoba, TD, Bartolome, CC, Roca, LG, Painceiras, MF, Miro, CM, Canfield, H, Jesus, S, Aguilar, M, Pastor, P, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Dotor, J, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JMC, Alonso, PS, Losada, MAG, Ariztegui, NL, Gaston, I, Kulisevsky, J, Estrada, MB, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, de Fabregues, O, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LLM, McAfee, D, Martinez-Martin, P, Mir, P. Diplopia Is Frequent and Associated with Motor and Non-Motor Severity in Parkinson's Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up. Diagnostics. 2021; 11(12)DOI:10.3390/diagnostics11122380. PMID:34943619. IF:3.992(Q2/4D).

Gaig, C, Compta, Y, Heidbreder, A, Marti, MJ, Titulaer, MJ, Crijnen, Y, Hogl, B, Lewerenz, J, Erro, ME, Garcia-Monco, JC, Nigro, P, Tambasco, N, Patalong-Ogiewa, M, Erdler, M, Macher, S, Berger-Sieczkowski, E, Hoftberger, R, Geis, C, Hutterer, M, Milan-Tomas, A, Martin-Bastida, A, Manzanares, LL, Quintas, S, Hoglinger, GU, Mohn, N, Schoberl, F, Thaler, FS, Asioli, GM, Provini, F, Plazzi, G, Berganzo, K, Blaabjerg, M, Bruggemann, N, Farias, T, Ng, CF, Giordana, C, Herrero-San Martin, A, Huebra, L, Kotschet, K, Liendl, H, Montojo, T, Morata, C, Perez, JP, Puertas, I, Seifert-Held, T, Seitz, C, Simabukuro, MM, Tellez, N, Villacieros-Alvarez, J, Willekens, B, Sabater, L, Iranzo, A, Cano, JS, Dalmau, J, Graus, F. Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease. NEUROLOGY. 2021; 97(14)DOI:10.1212/WNL.0000000000012639. PMID:34380749. IF:12.258(Q1/1D).

Pagano, G, Boess, FG, Taylor, KI, Ricci, B, Mollenhauer, B, Poewe, W, Boulay, A, Anzures-Cabrera, J, Vogt, A, Marchesi, M, Post, A, Nikolcheva, T, Kinney, GG, Zago, WM, Ness, DK, Svoboda, H, Britschgi, M, Ostrowitzki, S, Simuni, T, Marek, K, Koller, M, Sevigny, J, Doody, R, Fontoura, P, Umbricht, D, Bonni, A, PASADENA Investigators, Bejr-Kasem, H, Bojarsky J.K., Prasinezumab Study Grp. A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. Frontiers in Neurology. 2021; 12DOI:10.3389/fneur.2021.705407. PMID:34659081. IF:4.086(Q2/5D).

De Paepe, AE, Ara, A, Garcia-Gorro, C, Martinez-Horta, S, Perez-Perez, J, Kulisevsky, J, Rodriguez-Dechicha, N, Vaquer, I, Subira, S, Calopa, M, Munoz, E, Santacruz, P, Ruiz-Idiago, J, Mareca, C, de Diego-Balaguer, R, Camara, E. Gray Matter Vulnerabilities Predict Longitudinal Development of Apathy in Huntington's Disease. MOVEMENT DISORDERS. 2021; 36(9)DOI:10.1002/mds.28638. PMID:33998063. IF:9.698(Q1/1D).

Pagonabarraga, J, Tinazzi, M, Caccia, C, Jost, WH. The role of glutamatergic neurotransmission in the motor and non-motor symptoms in Parkinson's disease: Clinical cases and a review of the literature. JOURNAL OF CLINICAL NEUROSCIENCE. 2021; 90DOI:10.1016/j.jocn.2021.05.056. PMID:34275546. IF:2.116(Q4/9D).